A common diabetes drug could lower long COVID risk by 40%

Metformin, a common diabetes drug, was tested by researchers to see if it could stop long COVID. Metformin can cut down long COVID diagnoses by 40%, according to their research. If these results apply to the general population, more research is required. Having no connection to the study, board-certified family physician Dr. Daniel Kim of Medical Offices of Manhattan discusses how metformin may have decreased long COVID risk. Read the article.